GlobalData’s key thoughts from World EPA Congress 2026
GlobalData Healthcare recently attended the World Evidence, Pricing and Access (EPA) congress in Amsterdam on 3-4 March 2026. This conference…
Pricing and Market Access
Market instability expected from South Korea’s new pricing reform in 2026-2028
Have originator medicines’ list prices started to drop in the US?
Transformative arrival of oral weight loss medicines in the US
US comes up with two mandatory IRP use pricing models under Trump’s MFN strategy
China releases 2025 NRDL and first commercial insurance drug list
Win for pharma in UK – zero US tariffs, VPAG rate cap and NICE threshold increase
Slow progress as rare disease regulations in developing ASEAN states begin to take shape
